Remove digital upskilling-in-a-digital-health-world
article thumbnail

Upskilling in a digital health world

pharmaphorum

It’s no secret that digital technologies are playing a significant role when it comes to shaping the next era of healthcare. Necessity accelerated the adoption of new and sophisticated technologies and systems throughout the COVID-19 pandemic, but this seismic shift towards digital health has opened up a gap in education.

article thumbnail

Can Europe become a major player in cell and gene therapy?

Drug Discovery World

Despite the importance of the pharmaceutical industry to national economies and population health, the report paints a picture of falling competitiveness, with the global share of R&D investment, clinical trials and manufacturing output all decreasing. . The current situation . China has meanwhile grown its share from 1% to 8%. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conducting successful commercial research in a primary care setting

pharmaphorum

This was the subject of a recent pharmaphorum webinar , developed in association with the National Institute of Health and Care Research (NIHR) where a panel of industry experts gathered to discuss how to unlock the promise of primary care sites in commercial research. Developing the vision for the primary care setting.

article thumbnail

What will the 2023 drug discovery landscape look like?

Drug Discovery World

We’re calling this a virtual clinical trial, because we used real, deidentified patient data to simulate health outcomes,” says Wenrui Hao, Associate Professor of Mathematics at Penn State, lead author and co-principal investigator. The overall virtual clinical trials market is currently valued at $7.8

article thumbnail

From trial design for patients to trial design with patients: a key topic at DIA ’22

pharmaphorum

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally.

Trials 64
article thumbnail

Leveraging augmented analytics to drive better business decisions

pharmaphorum

In early 2020, health officials were cautious about forecasting a COVID-19 vaccine timeline to the public, as vaccine discovery was a historically laborious process that took years (if not decades). Yet a successful COVID-19 vaccine gained emergency approval in just 11 months, a blistering pace that likely saved millions of lives.

article thumbnail

Pharma’s response to COVID: Lilly and diabetes care

pharmaphorum

As COVID-19 turned the world on its head, healthcare services for people living with long-term conditions like diabetes, came under a huge strain. We had a general upskilling, as well, in diabetes to helps advance the treatment during this, as well.” ” Population health tools.